Cargando…
Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease which is often caused by recurrent emboli. These are also frequently found in patients with myeloproliferative diseases. While myeloproliferative diseases can be caused by gene defects, the genetic predisposition to CTEPH is lar...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246715/ https://www.ncbi.nlm.nih.gov/pubmed/32397294 http://dx.doi.org/10.3390/ijms21093339 |
_version_ | 1783538011274739712 |
---|---|
author | Eichstaedt, Christina A. Verweyen, Jeremias Halank, Michael Benjamin, Nicola Fischer, Christine Mayer, Eckhard Guth, Stefan Wiedenroth, Christoph B. Egenlauf, Benjamin Harutyunova, Satenik Xanthouli, Panagiota Marra, Alberto M. Wilkens, Heinrike Ewert, Ralf Hinderhofer, Katrin Grünig, Ekkehard |
author_facet | Eichstaedt, Christina A. Verweyen, Jeremias Halank, Michael Benjamin, Nicola Fischer, Christine Mayer, Eckhard Guth, Stefan Wiedenroth, Christoph B. Egenlauf, Benjamin Harutyunova, Satenik Xanthouli, Panagiota Marra, Alberto M. Wilkens, Heinrike Ewert, Ralf Hinderhofer, Katrin Grünig, Ekkehard |
author_sort | Eichstaedt, Christina A. |
collection | PubMed |
description | Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease which is often caused by recurrent emboli. These are also frequently found in patients with myeloproliferative diseases. While myeloproliferative diseases can be caused by gene defects, the genetic predisposition to CTEPH is largely unexplored. Therefore, the objective of this study was to analyse these genes and further genes involved in pulmonary hypertension in CTEPH patients. A systematic screening was conducted for pathogenic variants using a gene panel based on next generation sequencing. CTEPH was diagnosed according to current guidelines. In this study, out of 40 CTEPH patients 4 (10%) carried pathogenic variants. One patient had a nonsense variant (c.2071A>T p.Lys691*) in the BMPR2 gene and three further patients carried the same pathogenic variant (missense variant, c.1849G>T p.Val617Phe) in the Janus kinase 2 (JAK2) gene. The latter led to a myeloproliferative disease in each patient. The prevalence of this JAK2 variant was significantly higher than expected (p < 0.0001). CTEPH patients may have a genetic predisposition more often than previously thought. The predisposition for myeloproliferative diseases could be an additional risk factor for CTEPH development. Thus, clinical screening for myeloproliferative diseases and genetic testing may be considered also for CTEPH patients. |
format | Online Article Text |
id | pubmed-7246715 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72467152020-06-10 Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study Eichstaedt, Christina A. Verweyen, Jeremias Halank, Michael Benjamin, Nicola Fischer, Christine Mayer, Eckhard Guth, Stefan Wiedenroth, Christoph B. Egenlauf, Benjamin Harutyunova, Satenik Xanthouli, Panagiota Marra, Alberto M. Wilkens, Heinrike Ewert, Ralf Hinderhofer, Katrin Grünig, Ekkehard Int J Mol Sci Article Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease which is often caused by recurrent emboli. These are also frequently found in patients with myeloproliferative diseases. While myeloproliferative diseases can be caused by gene defects, the genetic predisposition to CTEPH is largely unexplored. Therefore, the objective of this study was to analyse these genes and further genes involved in pulmonary hypertension in CTEPH patients. A systematic screening was conducted for pathogenic variants using a gene panel based on next generation sequencing. CTEPH was diagnosed according to current guidelines. In this study, out of 40 CTEPH patients 4 (10%) carried pathogenic variants. One patient had a nonsense variant (c.2071A>T p.Lys691*) in the BMPR2 gene and three further patients carried the same pathogenic variant (missense variant, c.1849G>T p.Val617Phe) in the Janus kinase 2 (JAK2) gene. The latter led to a myeloproliferative disease in each patient. The prevalence of this JAK2 variant was significantly higher than expected (p < 0.0001). CTEPH patients may have a genetic predisposition more often than previously thought. The predisposition for myeloproliferative diseases could be an additional risk factor for CTEPH development. Thus, clinical screening for myeloproliferative diseases and genetic testing may be considered also for CTEPH patients. MDPI 2020-05-08 /pmc/articles/PMC7246715/ /pubmed/32397294 http://dx.doi.org/10.3390/ijms21093339 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Eichstaedt, Christina A. Verweyen, Jeremias Halank, Michael Benjamin, Nicola Fischer, Christine Mayer, Eckhard Guth, Stefan Wiedenroth, Christoph B. Egenlauf, Benjamin Harutyunova, Satenik Xanthouli, Panagiota Marra, Alberto M. Wilkens, Heinrike Ewert, Ralf Hinderhofer, Katrin Grünig, Ekkehard Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study |
title | Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study |
title_full | Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study |
title_fullStr | Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study |
title_full_unstemmed | Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study |
title_short | Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study |
title_sort | myeloproliferative diseases as possible risk factor for development of chronic thromboembolic pulmonary hypertension—a genetic study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246715/ https://www.ncbi.nlm.nih.gov/pubmed/32397294 http://dx.doi.org/10.3390/ijms21093339 |
work_keys_str_mv | AT eichstaedtchristinaa myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT verweyenjeremias myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT halankmichael myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT benjaminnicola myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT fischerchristine myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT mayereckhard myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT guthstefan myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT wiedenrothchristophb myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT egenlaufbenjamin myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT harutyunovasatenik myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT xanthoulipanagiota myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT marraalbertom myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT wilkensheinrike myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT ewertralf myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT hinderhoferkatrin myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy AT grunigekkehard myeloproliferativediseasesaspossibleriskfactorfordevelopmentofchronicthromboembolicpulmonaryhypertensionageneticstudy |